000 | 01502 a2200385 4500 | ||
---|---|---|---|
005 | 20250515052458.0 | ||
264 | 0 | _c20070405 | |
008 | 200704s 0 0 eng d | ||
022 | _a0165-5728 | ||
024 | 7 |
_a10.1016/j.jneuroim.2006.11.027 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aTaylor, Jude Matthew | |
245 | 0 | 0 |
_aSoluble TNFR1 inhibits the development of experimental autoimmune neuritis by modulating blood-nerve-barrier permeability and inflammation. _h[electronic resource] |
260 |
_bJournal of neuroimmunology _cFeb 2007 |
||
300 |
_a118-24 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntibodies _xadministration & dosage |
650 | 0 | 4 |
_aBlood-Brain Barrier _xdrug effects |
650 | 0 | 4 |
_aCapillary Permeability _xdrug effects |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 |
_aEncephalomyelitis, Autoimmune, Experimental _xchemically induced |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aInflammation _xetiology |
650 | 0 | 4 |
_aMacrophages _xdrug effects |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMyelin Sheath _ximmunology |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Inbred Lew |
650 | 0 | 4 |
_aReceptors, Tumor Necrosis Factor, Type I _xadministration & dosage |
650 | 0 | 4 | _aTime Factors |
700 | 1 | _aPollard, John David | |
773 | 0 |
_tJournal of neuroimmunology _gvol. 183 _gno. 1-2 _gp. 118-24 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jneuroim.2006.11.027 _zAvailable from publisher's website |
999 |
_c16763467 _d16763467 |